Thailand Extends Medical Device Annual Reporting Deadline: What Manufacturers Need to Know

Recent regulatory developments in Thailand are drawing the attention of medical device manufacturers and regulatory professionals across Asia.

The Thai Food and Drug Administration has announced an extension of the medical device annual reporting deadline, allowing companies additional time to comply with regulatory reporting obligations. The deadline has now been extended to 31 May 2026, alongside revisions to sales reporting requirements for medical device companies operating in the Thai market.

This update reflects the regulator’s ongoing efforts to streamline compliance processes while ensuring continued oversight of medical devices available in the market.

Understanding the Annual Reporting Requirement

In Thailand, companies holding medical device registrations are required to submit annual reports detailing product sales and distribution data. These reports allow regulators to monitor:

• The availability of medical devices in the market

• Distribution volumes and supply trends

• Post-market compliance activities

Such reporting plays an important role in ensuring that medical devices remain safe, traceable, and properly monitored throughout their lifecycle.

What Has Changed in 2026?

The recent announcement introduces an extended deadline for submitting annual reports, giving companies more time to prepare their regulatory documentation.

Key points of the update include:

• The annual reporting deadline has been extended to 31 May 2026.

• Updates to sales reporting requirements for registered medical devices.

• Continued regulatory monitoring of market activity and product distribution.

This change provides manufacturers and importers with additional flexibility, particularly those managing large product portfolios or complex distribution networks.

Implications for Medical Device Manufacturers

Companies supplying medical devices to Thailand should take note of this update and review their reporting procedures.

Manufacturers and importers are encouraged to:

• Verify their medical device reporting obligations

• Ensure accurate sales and distribution records are maintained

• Prepare annual reports in accordance with the updated timeline

• Monitor further regulatory announcements from Thai authorities

  
  

Failure to comply with reporting requirements may lead to regulatory penalties or delays in maintaining device registrations.

Thailand’s Evolving Regulatory Landscape

Thailand continues to modernise its regulatory framework for medical devices. Recent updates introduced by the Thai Food and Drug Administration also include:

• Digitalisation of regulatory submission processes

• Updated labelling requirements for medical devices

• Revised regulatory procedures for manufacturers and importers

These developments demonstrate Thailand’s commitment to strengthening oversight while supporting innovation and access to medical technologies.

How ARQon Can Support

Navigating regulatory updates across Asia requires continuous monitoring and expert guidance.

At ARQon International Group, we support medical device companies with:

• Regulatory intelligence and monitoring across Asia

• Medical device registration and compliance support

• Market entry strategies in ASEAN markets

• Post-market regulatory obligations

• 
  

By staying ahead of regulatory changes such as Thailand’s reporting updates, companies can ensure smooth market access and continued compliance in one of Southeast Asia’s key healthcare markets.